Skip to main content
Category

News Archive

edge-baltimore-logo

Emerging & Developing Global Executives Program – Now Accepting Nominations for EDGE 2017/18 Class

By News Archive

edge-baltimore-logo

Seeking Emerging International Business Leaders to Join the EDGE Program

We are now accepting applications for the next class of the Emerging and Developing Global Executives (EDGE) Program. The inaugural program was a great success (hear from the Bowe Fellows in their own words), and this year’s group is off to a great start.

Bowe Fellows are a diverse group of globally minded leaders from the Baltimore area who have had significant career trajectories, generally with 10+ years of business experience. They are currently in or transitioning to roles in international operations and possess future growth potential within their companies.

Read More
pmwc-2017-logo

PMWC – Precision Medicine World Conference 2017 Silicon Valley

By News Archive

pmwc-2017-logo

An update on the Cancer Moonshot Initiative and more at the 11th PMWC 2017 Silicon Valley with 250+ speakers and 50+ sessions

While its creation was only announced earlier this year, with Vice President Joe Biden at the helm instilling hope and calling for action, the Cancer Moonshot may shockingly be nearing its end, as we know it. Uncertainties overshadow the future of this initiative as the White House Cancer Task Force is expected to exist in its current configuration only until the end of the Obama Administration, January 20, 2017.

Read More
dna-tech-company-pixa

How to Discover Your Company’s DNA

By News Archive

dna-tech-company-pixa

The term “company DNA” is sometimes used as a shorthand for an organization’s culture and strategy — a metaphor for what makes it unique.  But there may be more to the metaphor. Understanding your company’s DNA can help you know what you can and can’t do, and how to achieve agility and authenticity in a changing world.

Read More
blueprint-brain-health-pixa

A Blueprint for Measuring Health Care Outcomes

By News Archive

blueprint-brain-health-pixa

The starting point for achieving value in any health care system is to measure outcomes. Although this can present leadership challenges related to shifting strategy, culture and operations, it certainly isn’t rocket science. There are hundreds of provider organizations the world over that have already implemented outcomes measurement, and this number increases every week. Regardless, many providers still believe that measuring outcomes is too difficult to do.

Read More
julie-lenzer-umd-image

Lenzer to Cultivate UMD Innovation-Based Economic Development Efforts

By News Archive

julie-lenzer-umd-imageThe University of Maryland (UMD) today announced the appointment of Julie Lenzer as Associate Vice President for Economic Development, effective December 12, 2016. Lenzer will also serve as Director of UM Ventures – College Park in the UMD Division of Research.

Lenzer is an award-winning software entrepreneur, ecosystem builder, investor, and educator with a foundation in innovation-based economic development.

Read More
nhlbi-nih-logo

NHLBI Funding & Research Opportunities and Announcements for December 12, 2016

By News Archive

nhlbi-nih-logo

Funding and Research Opportunities
The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:

Notices:

  • Notice of Extension of the Response Date for NOT-OD-17-015 “Strategies for 
    • NIH Data Management, Sharing, and Citation”
    • (NOT-OD-17-025) National Institutes of Health
  • Revision: Participation of the National Institute of Dental and Craniofacial 
    • Research (NIDCR) in PAR-15-282 “Multidisciplinary Studies of HIV/AIDS and 
    • Aging (R21)” 
    • (NOT-DE-17-005)
    • National Institute of Dental and Craniofacial Research
  • Request for Information (RFI): Biological Mechanisms/Pathways of the Combined 
    • Effects of Chemical and Non-chemical Stressors Associated with Atherosclerosis
    • (NOT-ES-17-003)
    • National Institute of Environmental Health Sciences
    • National Heart, Lung, and Blood Institute
  • Notice of Intent to Publish a Funding Opportunity Announcement for Catalyzing 
    • Innovation in Late Phase Clinical Trial Design and Statistical Analysis Plans 
    • (U34) 
    • (NOT-HL-16-473)
    • National Heart, Lung, and Blood Institute
  • Notice of Intent to Publish a Funding Opportunity Announcement for Catalyzing 
    • Innovation in Late Phase Clinical Trial Design and Statistical Analysis Plans 
    • (X01)
    • (NOT-HL-16-474)
    • National Heart, Lung, and Blood Institute
  • Notice of Intent to Publish a Funding Opportunity Announcement for NHLBI Early 
    • Phase Clinical Trials for Therapeutics and/or Diagnostics (R61/R33)
    • (NOT-HL-16-475)
    • National Heart, Lung, and Blood Institute
  • Notice of Intent to Publish a Funding Opportunity Announcement for Sex 
    • Hormone Induced Thromboembolism in Pre-Menopausal Women (R61/R33) 
    • (NOT-HL-16-477)
    • National Heart, Lung, and Blood Institute
  • Soon to be Issued Funding Opportunity for All of Us Research Program 
    • Community Engagement (OT2) 
    • (NOT-PM-17-001)
    • National Institutes of Health
  • Notice of Change to Background for RFA-RM-16-024 “Knowledge Management 
    • Center for Illuminating the Druggable Genome (U24)”
    • (NOT-RM-17-002)
    • NIH Roadmap Initiatives
  • Notice of Change to Background for RFA-RM-16-025 “Resource Dissemination and Outreach Center for Illuminating the Druggable Genome (U24)”
  • Notice of Change to Background for RFA-RM-16-026 “Data and Resource 
    • Generation Centers for Illuminating the Druggable Genome (U24)”
    • (NOT-RM-17-004)
    • NIH Roadmap Initiatives
silense-shush-pixa

Here’s what VCs and the medtech industry don’t want you to know – MedCity News

By News Archive

silense-shush-pixa

The one thing venture capitalists and the medtech industry don’t want you to know is that innovation can sometimes be used as a manipulation to evade the law.

The industry can sometimes, even knowingly, be deceptive in three very specific ways. These are: lie to government agencies, underreport adverse events, blame the employees and consumer (victims). My goal as a federal whistleblower is to explain how these at times carefully crafted lies impacts each of you.

Read More

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.